文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

中医药在溃疡性结肠炎治疗中的应用及相关机制阐释

Application of Chinese Medicine in Treatment of Ulcerative Colitis and Elucidation of Relevant Mechanisms.

作者信息

Zhu Ji-Wei, Wang Han-Ming, Aisikaer Muaitaer, Zhou Wen-Jun, Yang Tong-Tong, Aximujiang Kasimujiang

机构信息

Xinjiang Medical University, Urumqi, 830017, China.

Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xinjiang Medical University, Urumqi, 830017, China.

出版信息

Chin J Integr Med. 2025 Jan 17. doi: 10.1007/s11655-025-3824-y.


DOI:10.1007/s11655-025-3824-y
PMID:39821880
Abstract

Ulcerative colitis (UC) is a chronic, non-specific intestinal disease of unknown etiology, with high incidence rates worldwide. At present, Western medicine treatments have been associated with more adverse effects and poor efficacy. Chinese medicine (CM) is commonly used as an adjuvant treatment for the unique advantages in regulating immune function, repairing intestinal mucosa, and alleviating intestinal inflammation. At the same time, network pharmacology is also providing new ideas and innovations about CM and development of new drugs. This review systematically discusses the progress of research regarding UC treatment using CM, with a main focus on intestinal flora balance, intestinal mucosal barrier, CM enema, acupuncture therapy, and acupoint embedding. This study provides new ideas that clarify the therapeutic targets of UC.

摘要

溃疡性结肠炎(UC)是一种病因不明的慢性非特异性肠道疾病,在全球范围内发病率较高。目前,西医治疗不良反应较多且疗效不佳。中药因其在调节免疫功能、修复肠黏膜和减轻肠道炎症方面具有独特优势,常被用作辅助治疗。同时,网络药理学也为中药及新药研发提供了新的思路和创新。本综述系统地讨论了中药治疗UC的研究进展,主要聚焦于肠道菌群平衡、肠黏膜屏障、中药灌肠、针灸疗法和穴位埋线。本研究为阐明UC的治疗靶点提供了新思路。

相似文献

[1]
Application of Chinese Medicine in Treatment of Ulcerative Colitis and Elucidation of Relevant Mechanisms.

Chin J Integr Med. 2025-1-17

[2]
Traditional Chinese Medicine: A promising strategy to regulate the imbalance of bacterial flora, impaired intestinal barrier and immune function attributed to ulcerative colitis through intestinal microecology.

J Ethnopharmacol. 2024-1-10

[3]
Integrated Network Pharmacology, Molecular Docking and Animal Experiment to Explore the Efficacy and Potential Mechanism of Baiyu Decoction Against Ulcerative Colitis by Enema.

Drug Des Devel Ther. 2023

[4]
Huanglian Ganjiang Decoction alleviates DSS-induced colitis through suppressing inflammation and protecting intestinal barrier: From the perspective of disassembling prescriptions.

J Ethnopharmacol. 2025-2-11

[5]
Anemone chinensis Bunge aqueous enema alleviates dextran sulfate sodium-induced colitis via inhibition of inflammation and regulation of the colonic mucosal microbiota.

J Ethnopharmacol. 2022-4-24

[6]
suppresses gut microbiota related TNF inflammatory pathway to alleviates ulcerative colitis.

Front Immunol. 2025-4-22

[7]
Blockade of PI3K/AKT signaling pathway by Astragaloside IV attenuates ulcerative colitis via improving the intestinal epithelial barrier.

J Transl Med. 2024-4-30

[8]
[Research progress of traditional Chinese medicine intervention for ulcerative colitis based on Notch1 signaling pathway].

Zhongguo Zhong Yao Za Zhi. 2024-4

[9]
Repairing the intestinal mucosal barrier of traditional Chinese medicine for ulcerative colitis: a review.

Front Pharmacol. 2023-10-24

[10]
Network pharmacology dissection of multiscale mechanisms for jiaoqi powder in treating ulcerative colitis.

J Ethnopharmacol. 2021-7-15

本文引用的文献

[1]
Limosilactobacillus fermentum HF06-derived paraprobiotic and postbiotic alleviate intestinal barrier damage and gut microbiota disruption in mice with ulcerative colitis.

J Sci Food Agric. 2024-2

[2]
Higenamine improves DSS-induced ulcerative colitis in mice through the Galectin-3/TLR4/NF-κB pathway.

Tissue Cell. 2023-6

[3]
The immunomodulatory mechanisms for acupuncture practice.

Front Immunol. 2023

[4]
Herba Origani alleviated DSS-induced ulcerative colitis in mice through remolding gut microbiota to regulate bile acid and short-chain fatty acid metabolisms.

Biomed Pharmacother. 2023-5

[5]
Gallic acid ameliorates dextran sulfate sodium-induced ulcerative colitis in mice inhibiting NLRP3 inflammasome.

Front Pharmacol. 2023-1-25

[6]
Strains producing different short-chain fatty acids alleviate DSS-induced ulcerative colitis by regulating intestinal microecology.

Food Funct. 2022-11-28

[7]
Tight junction formation by a claudin mutant lacking the COOH-terminal PDZ domain-binding motif.

Ann N Y Acad Sci. 2022-10

[8]
and HKL Suspension Alleviates Ulcerative Colitis in Rats by Regulating Gut Microbiota, Suppressing TLR9, and Promoting Metabolism.

Front Pharmacol. 2022-5-4

[9]
Bile Acids: Key Players in Inflammatory Bowel Diseases?

Cells. 2022-3-5

[10]
Bile Acid-Gut Microbiota Axis in Inflammatory Bowel Disease: From Bench to Bedside.

Nutrients. 2021-9-9

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索